|
Volumn 17, Issue 6, 2008, Pages 383-390
|
Optimizing the treatment of type 2 diabetes using current and future insulin technologies.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDIABETIC AGENT;
DRUG DERIVATIVE;
GLYCOSYLATED HEMOGLOBIN;
INSULIN;
CHILD;
DECISION MAKING;
FORECASTING;
HUMAN;
INFUSION PUMP;
INSULIN INFUSION;
JET INJECTION;
METABOLISM;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NURSE ATTITUDE;
NURSING;
PATIENT ATTITUDE;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
REVIEW;
SUBCUTANEOUS DRUG ADMINISTRATION;
SYRINGE;
TIME;
CHILD;
CHOICE BEHAVIOR;
DIABETES MELLITUS, TYPE 2;
FORECASTING;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INFUSION PUMPS, IMPLANTABLE;
INJECTIONS, JET;
INJECTIONS, SUBCUTANEOUS;
INSULIN;
INSULIN INFUSION SYSTEMS;
MIDDLE AGED;
NURSE'S ROLE;
PATIENT ACCEPTANCE OF HEALTH CARE;
PATIENT EDUCATION AS TOPIC;
PRACTICE GUIDELINES AS TOPIC;
SYRINGES;
TIME FACTORS;
|
EID: 64049092721
PISSN: 10920811
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (68)
|